{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:16:53Z","timestamp":1790749013880,"version":"4.1.0"},"reference-count":35,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T00:00:00Z","timestamp":1379635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Histopathology"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>30 expression by bone marrow (<jats:styled-content style=\"fixed-case\">BM<\/jats:styled-content>) mast cells (<jats:styled-content style=\"fixed-case\">MC<\/jats:styled-content>) has been reported recently in systemic mastocytosis (<jats:styled-content style=\"fixed-case\">SM<\/jats:styled-content>) patients. The aim of this study was to investigate the potential diagnostic and prognostic value of <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>30 expression in <jats:styled-content style=\"fixed-case\">SM<\/jats:styled-content> as assessed by multiparameter flow cytometry.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and results<\/jats:title><jats:p>A total of 163 consecutive <jats:styled-content style=\"fixed-case\">BM<\/jats:styled-content> samples corresponding to 142 <jats:styled-content style=\"fixed-case\">SM<\/jats:styled-content> patients and 21 non\u2010mastocytosis cases were studied. <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>30 was positive in most <jats:styled-content style=\"fixed-case\">SM<\/jats:styled-content> patients (80%), but in only one non\u2010mastocytosis case (4.8%). When combined with <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>25, <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>30 contributed to an improved accuracy over that of <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>25 alone (98% versus 93%) mainly because most (eight of nine) of the well\u2010differentiated <jats:styled-content style=\"fixed-case\">SM<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">WDSM<\/jats:styled-content>), who lacked <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>25, were <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>30<jats:sup>+<\/jats:sup>. Similar levels of expression of <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>30 were observed among all different subgroups of <jats:styled-content style=\"fixed-case\">SM<\/jats:styled-content> except mast cell leukaemia; among indolent <jats:styled-content style=\"fixed-case\">SM<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">ISM<\/jats:styled-content>) patients, no significant association was observed between the levels of <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>30 expression and other clinical and biological features of the disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The increased expression of <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>30 associated with absence of <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>25 contributes to the diagnosis of <jats:styled-content style=\"fixed-case\">WDSM<\/jats:styled-content> and its distinction from other subtypes of <jats:styled-content style=\"fixed-case\">SM<\/jats:styled-content>. By contrast, <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>30 expression did not contribute either to prognostic stratification of <jats:styled-content style=\"fixed-case\">ISM<\/jats:styled-content> or to the differential diagnosis between <jats:styled-content style=\"fixed-case\">ISM<\/jats:styled-content> and aggressive <jats:styled-content style=\"fixed-case\">SM<\/jats:styled-content> cases.<\/jats:p><\/jats:sec>","DOI":"10.1111\/his.12221","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T10:24:08Z","timestamp":1372933448000},"page":"780-787","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["<scp>CD<\/scp>30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis"],"prefix":"10.1111","volume":"63","author":[{"given":"Jos\u00e9 M","family":"Morgado","sequence":"first","affiliation":[{"name":"Instituto de Estudios de Mastocitosis de Castilla La Mancha Toledo Spain"},{"name":"Red Espa\u00f1ola de Mastocitosis Toledo Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Perbellini","sequence":"additional","affiliation":[{"name":"Section of Haematology Azienda Ospedaliera Universitaria Integrata and University of Verona Verona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan C","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Pathology School of Medicine Stanford University Stanford CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Teod\u00f3sio","sequence":"additional","affiliation":[{"name":"Red Espa\u00f1ola de Mastocitosis Toledo Spain"},{"name":"Servicio General de Citometr\u00eda, Centro de Investigaci\u00f3n del C\u00e1ncer (IBMCC\u2010CSIC\/USAL; IBSAL) and Departamento de Medicina Universidad de Salamanca Salamanca Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"Matito","sequence":"additional","affiliation":[{"name":"Instituto de Estudios de Mastocitosis de Castilla La Mancha Toledo Spain"},{"name":"Red Espa\u00f1ola de Mastocitosis Toledo Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"\u00c1lvarez\u2010Twose","sequence":"additional","affiliation":[{"name":"Instituto de Estudios de Mastocitosis de Castilla La Mancha Toledo Spain"},{"name":"Red Espa\u00f1ola de Mastocitosis Toledo Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Bonadonna","sequence":"additional","affiliation":[{"name":"Allergy Service Azienda Ospedaliera Universitaria Integrata and University of Verona Verona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Zam\u00f2","sequence":"additional","affiliation":[{"name":"Section of Pathological Anatomy Azienda Ospedaliera Universitaria Integrata and University of Verona Verona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Jara\u2010Acevedo","sequence":"additional","affiliation":[{"name":"Red Espa\u00f1ola de Mastocitosis Toledo Spain"},{"name":"Servicio General de Citometr\u00eda, Centro de Investigaci\u00f3n del C\u00e1ncer (IBMCC\u2010CSIC\/USAL; IBSAL) and Departamento de Medicina Universidad de Salamanca Salamanca Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mayado","sequence":"additional","affiliation":[{"name":"Red Espa\u00f1ola de Mastocitosis Toledo Spain"},{"name":"Servicio General de Citometr\u00eda, Centro de Investigaci\u00f3n del C\u00e1ncer (IBMCC\u2010CSIC\/USAL; IBSAL) and Departamento de Medicina Universidad de Salamanca Salamanca Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Garcia\u2010Montero","sequence":"additional","affiliation":[{"name":"Red Espa\u00f1ola de Mastocitosis Toledo Spain"},{"name":"Servicio General de Citometr\u00eda, Centro de Investigaci\u00f3n del C\u00e1ncer (IBMCC\u2010CSIC\/USAL; IBSAL) and Departamento de Medicina Universidad de Salamanca Salamanca Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Mollejo","sequence":"additional","affiliation":[{"name":"Red Espa\u00f1ola de Mastocitosis Toledo Spain"},{"name":"Department of Pathology Hospital Virgen de la Salud Toledo Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy I","family":"George","sequence":"additional","affiliation":[{"name":"Department of Pathology School of Medicine Stanford University Stanford CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Zanotti","sequence":"additional","affiliation":[{"name":"Section of Haematology Azienda Ospedaliera Universitaria Integrata and University of Verona Verona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Orfao","sequence":"additional","affiliation":[{"name":"Red Espa\u00f1ola de Mastocitosis Toledo Spain"},{"name":"Servicio General de Citometr\u00eda, Centro de Investigaci\u00f3n del C\u00e1ncer (IBMCC\u2010CSIC\/USAL; IBSAL) and Departamento de Medicina Universidad de Salamanca Salamanca Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Escribano","sequence":"additional","affiliation":[{"name":"Red Espa\u00f1ola de Mastocitosis Toledo Spain"},{"name":"Servicio General de Citometr\u00eda, Centro de Investigaci\u00f3n del C\u00e1ncer (IBMCC\u2010CSIC\/USAL; IBSAL) and Departamento de Medicina Universidad de Salamanca Salamanca Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"S\u00e1nchez\u2010Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Instituto de Estudios de Mastocitosis de Castilla La Mancha Toledo Spain"},{"name":"Red Espa\u00f1ola de Mastocitosis Toledo Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,9,20]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(01)00041-8"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199809000-00013"},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1182\/blood.V91.8.2731.2731_2731_2736","article-title":"Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications","volume":"91","author":"Escribano L","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.10.020"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(01)00038-8"},{"key":"e_1_2_6_7_1","first-page":"54","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Horny H\u2010P","year":"2008"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2007.01807.x"},{"key":"e_1_2_6_9_1","first-page":"291","volume-title":"WHO classification of tumours. Pathology and genetics. Tumours of haematopoietic and lymphoid tissues","author":"Valent P","year":"2001"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2010.224"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2010.550072"},{"key":"e_1_2_6_12_1","doi-asserted-by":"crossref","unstructured":"MoonimTM KossierT van DerWaltJ WilkinsB HarrisonCN RadiaDH.CD30\/CD123 expression in systemic mastocytosis does not correlate with aggressive disease. 54th ASH Annual Meeting and Exposition 2012;Atlanta GA: Abstract no. 1746.","DOI":"10.1182\/blood.V120.21.1746.1746"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/299065a0"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V66.4.848.848"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90180-K"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1006\/clim.1998.4636"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.1.1.bloodjournal8511"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.4.2186"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.84"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.01.683"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(01)00021-2"},{"key":"e_1_2_6_22_1","first-page":"6.6.1","article-title":"Immunophenotypic analysis of human mast cells by flow cytometry","volume":"6","author":"Escribano L","year":"2001","journal-title":"Curr. Protoc. Cytom."},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.20606"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.10072"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.20092"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-015545"},{"key":"e_1_2_6_27_1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/ajcp\/102.3.292","article-title":"CD30 antigen expression in florid immunoblastic proliferations. A clinicopathologic study of 14 cases","volume":"102","author":"Segal GH","year":"1994","journal-title":"Am. J. Clin. Pathol."},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.58.6.683"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.192"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-11-3816"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.9973"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02977.x"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e32834bb8a7"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2012.673578"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.20230"},{"key":"e_1_2_6_36_1","doi-asserted-by":"crossref","unstructured":"MehtaA ReddyVVB BorateU.Anti CD\u201030 Antibody\u2013drug conjugate brentuximab vedotin (ADCETRIS) may be a promising treatment option for systemic mastocytosis. 54th ASH Annual Meeting and Exposition 2012;Atlanta GA; Abstract no. 2857.","DOI":"10.1182\/blood.V120.21.2857.2857"}],"container-title":["Histopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhis.12221","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/his.12221","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T21:05:54Z","timestamp":1696367154000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/his.12221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,20]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["10.1111\/his.12221"],"URL":"https:\/\/doi.org\/10.1111\/his.12221","archive":["Portico"],"relation":{},"ISSN":["0309-0167","1365-2559"],"issn-type":[{"value":"0309-0167","type":"print"},{"value":"1365-2559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,20]]},"assertion":[{"value":"2013-02-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-07-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-09-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}